Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$13.89 USD
+0.43 (3.19%)
Updated May 7, 2024 04:00 PM ET
After-Market: $13.90 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for ORTHOFIX MEDICAL INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -151.40 | -19.75 | -38.38 | 2.52 | -28.46 |
Depreciation/Amortization & Depletion | 96.61 | 32.08 | 44.85 | 34.28 | 28.48 |
Net Change from Assets/Liabilities | -53.96 | -29.24 | -24.70 | 19.70 | -29.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 63.00 | 5.37 | 36.70 | 17.78 | 61.40 |
Net Cash From Operating Activities | -45.75 | -11.54 | 18.48 | 74.27 | 32.03 |
Property & Equipment | -62.05 | -24.53 | -19.59 | -24.33 | -22.92 |
Acquisition/ Disposition of Subsidiaries | 29.42 | 0.00 | -1.25 | -18.00 | 0.00 |
Investments | 0.00 | 0.00 | -2.17 | -10.00 | 0.00 |
Other Investing Activities | -0.50 | -1.80 | -1.81 | -1.61 | -1.53 |
Net Cash from Investing Activities | -33.13 | -24.53 | -23.01 | -52.33 | -22.92 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.13 | 4.34 | 8.82 | 7.60 | 11.55 |
Issuance (Repayment) of Debt | -27.55 | -2.59 | -0.54 | -0.32 | -0.37 |
Increase (Decrease) Short-Term Debt | 95.50 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.75 | -1.82 | -11.91 | -4.03 | -21.87 |
Net Cash from Financing Activities | 65.32 | -0.08 | -3.62 | 3.25 | -10.69 |
Effect of Exchange Rate Changes | 0.62 | -1.00 | -0.82 | 1.24 | -0.21 |
Net Change In Cash & Equivalents | -12.94 | -37.15 | -8.97 | 26.42 | -1.79 |
Cash at Beginning of Period | 50.70 | 87.85 | 96.82 | 70.40 | 72.19 |
Cash at End of Period | 37.76 | 50.70 | 87.85 | 96.82 | 70.40 |
Diluted Net EPS | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 |
Fiscal Year End for ORTHOFIX MEDICAL INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -151.40 | -129.22 | -100.36 | -60.94 |
Depreciation/Amortization & Depletion | NA | 96.61 | 72.61 | 50.40 | 26.00 |
Net Change from Assets/Liabilities | NA | -53.96 | -39.54 | -32.04 | -19.51 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 63.00 | 57.10 | 42.46 | 20.43 |
Net Cash From Operating Activities | NA | -45.75 | -39.06 | -39.54 | -34.02 |
Property & Equipment | NA | -62.05 | -47.00 | -24.65 | -11.84 |
Acquisition/ Disposition of Subsidiaries | NA | 29.42 | 29.42 | 29.42 | 29.42 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -0.50 | -0.50 | -0.50 | -0.50 |
Net Cash from Investing Activities | NA | -33.13 | -18.08 | 4.27 | 17.08 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 5.13 | 2.38 | 2.38 | 0.00 |
Issuance (Repayment) of Debt | NA | -27.55 | -0.48 | -0.32 | -27.06 |
Increase (Decrease) Short-Term Debt | NA | 95.50 | 70.00 | 51.00 | 45.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -7.75 | -31.85 | -31.27 | -1.96 |
Net Cash from Financing Activities | NA | 65.32 | 40.04 | 21.79 | 15.98 |
Effect of Exchange Rate Changes | NA | 0.62 | 0.06 | 0.39 | 0.22 |
Net Change In Cash & Equivalents | NA | -12.94 | -17.04 | -13.09 | -0.73 |
Cash at Beginning of Period | NA | 50.70 | 50.70 | 50.70 | 50.70 |
Cash at End of Period | NA | 37.76 | 33.66 | 37.61 | 49.97 |
Diluted Net EPS | NA | -0.57 | -0.77 | -1.07 | -1.71 |